These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9927228)

  • 41. Exogenous sex hormones and thrombophilia.
    Walker ID
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):467-79, x. PubMed ID: 16962922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An update on menopausal hormone replacement therapy in women and cardiovascular disease.
    Valdiviezo C; Lawson S; Ouyang P
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):148-55. PubMed ID: 23422240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
    Arnold JD; Sarkodie EP; Coleman ME; Goldstein DA
    J Sex Med; 2016 Nov; 13(11):1773-1777. PubMed ID: 27671969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 45. Hormone replacement therapy and venous thromboembolism.
    Walker ID
    Thromb Res; 2005 Feb; 115 Suppl 1():88-92. PubMed ID: 15790166
    [No Abstract]   [Full Text] [Related]  

  • 46. Estrogen replacement therapy is not conducive of venous thromboembolism.
    Young RL; Goepfert AR; Goldzieher HW
    Maturitas; 1991 Sep; 13(3):189-92. PubMed ID: 1943826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
    Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
    JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Practical strategies for hormone replacement therapy and risk of venous thromboembolism.
    Greer IA
    Br J Obstet Gynaecol; 1998 Apr; 105(4):376-9. PubMed ID: 9609259
    [No Abstract]   [Full Text] [Related]  

  • 49. Common risk factors for both arterial and venous thrombosis.
    Lowe GD
    Br J Haematol; 2008 Mar; 140(5):488-95. PubMed ID: 18275426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology and risk factors of venous thromboembolism.
    Ageno W; Squizzato A; Garcia D; Imberti D
    Semin Thromb Hemost; 2006 Oct; 32(7):651-8. PubMed ID: 17024592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
    Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patch instead of pill: a safer menopausal estrogen?
    Cushman M
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
    Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H; de Moerloose P; Campana A
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormones and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case-control study of venous thromboembolism risk in users of hormone replacement therapy.
    Daly E; Vessey MP; Painter R; Hawkins MM
    Lancet; 1996 Oct; 348(9033):1027. PubMed ID: 8855869
    [No Abstract]   [Full Text] [Related]  

  • 57. Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: results from the Danish Osteoporosis Prevention Study (DOPS).
    Kristensen SR; Abrahamsen B; Madsen JS; Gram J; Rejnmark L; Rud B; Jespersen J
    Thromb Haemost; 2006 May; 95(5):915-6. PubMed ID: 16676096
    [No Abstract]   [Full Text] [Related]  

  • 58. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
    Połać I; Borowiecka M; Wilamowska A; Nowak P
    Gynecol Endocrinol; 2013 Feb; 29(2):165-8. PubMed ID: 23116237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis.
    Mohammed K; Abu Dabrh AM; Benkhadra K; Al Nofal A; Carranza Leon BG; Prokop LJ; Montori VM; Faubion SS; Murad MH
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4012-20. PubMed ID: 26544651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
    Motolese M
    Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.